PXL 20210117 021127046Every medical disease and disorder is, no doubt, considering the specific impacts of COVID-19 to their population. Did you know that a drug commonly used in the Hereditary Alpha Tryptasemia Syndrome (HATS), Mastocytosis, and mast cell disorder populations has shown tentative antiviral effects? And have you or anyone you know with HATS tested positive for COVID-19?

This article will be modified as time goes by, to include observations, as we become aware of them.

News:

Many patients with mast cell disorders utilize certain drugs as "levers." In other words, they have a baseline of normal drugs they utilize, but they have certain ones that they utilize on a PRN basis. Some medical professionals recommend that diphenhydramine be used that way. The idea is to only utilize it when it is actually needed, to maximize its effectiveness upon use. Ironically, one of those places where it might actually be needed, is in prevention of coronavirus, or COVID-19.

As it happens according to the University of Florida, "Three [of the] drugs — hydroxyzine, diphenhydramine and azelastine — showed direct, statistically significant antiviral effects on the SARS-CoV-2 virus." Source: http://explore.research.ufl.edu/existing-antihistamine-drugs-show-effectiveness-against-covid-19-virus-in-cell-testing.html

Patient Experiences

I am aware of at least 3 HATS patients who have tested positive for COVID-19. None of them have been hospitalized nor required oxygen. At time of press, these patients are into their 6th week of illness; while they are weeks past their COVID-negative notices, they have continued to experience the following symptoms:

  • Daily headaches
  • Lack of, or limited, smell
  • Lack of, or limited, taste
  • Tiredness/exhaustion

I also know of at least 2 HATS patients who have been exposed to others who were positive, yet did not contract it. One of them was on a daily dosage of diphenhydramine, also known as Benadryl™️.

 

______________

The contents of Tryptasemia.com, Tryptasemia.org, and Valutivity.com, such as text, graphics, images, and other material contained on the sites ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this site.

If you think you may have a medical emergency, call your doctor or 911 / 999 / your local emergency #, immediately. These sites' Content do not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the site. Reliance on any Content provided by the sites' employees, others appearing on the sites at the invitation of Tryptasemia.com/Tryptasemia.org, or other visitors to the Site is solely at your own risk.

Photos on the site are © Valutivity LLC, unless otherwise noted.